MediFind

Find a Doctor

Pia Raanani

Tel Aviv University
Female

Bio


Pia Raanani is in Petah Tiqwa, Israel. They have been an author on 153 peer reviewed articles in the past 15 years. Dr. Raanani's top three areas of expertise are Leukemia, Chronic Myelogenous Leukemia, and SVC Obstruction.

Contact

Petah Tiqwa, M, IL

Latest Research


Latest Advance
Study
  • Condition: Myelofibrosis
  • Journal: British journal of haematology
  • Treatment Used: Ruxolitinib
  • Number of Patients: 2233
  • Published —
This study evaluated the safety and effectiveness of ruxolitinib in patients with myelofibrosis.
Latest Advance
Study
  • Condition: Acute Myeloid Leukemia (AML)
  • Journal: Annals of hematology
  • Treatment Used: Venetoclax
  • Number of Patients: 23
  • Published —
This study evaluated the effectiveness of venetoclax for patients with acute myeloid leukemia (AML).
Latest Advance
Study
  • Condition: Thrombocytopenic Patients with Hematological Malignancy
  • Journal: Thrombosis and haemostasis
  • Treatment Used: Anti-Platelet Therapy (APT)
  • Number of Patients: 0
  • Published —
This study identified patient and physician characteristics associated with anti-platelet therapy (APT) management in thrombocytopenic patients with hematological malignancy.
Latest Advance
Study
  • Condition: Diffuse large B cell lymphoma
  • Journal: Hematological oncology
  • Treatment Used: Maintenance therapy
  • Number of Patients: 5122
  • Published —
The study aimed to determine the safety and effectiveness of maintenance therapy in diffuse large B cell lymphoma.
Latest Advance
Study
  • Condition: Myeloid Neoplasms
  • Journal: Clinical lymphoma, myeloma & leukemia
  • Treatment Used: Hypomethylating Agents (HMAs)
  • Number of Patients: 2184
  • Published —
This review of the literature compared hypomethylating agents (HMAs)-containing regimens with any other regimen administered to patients with myeloid neoplasms.
Latest Advance
Study
  • Condition: Hip fracture in patients receiving vitamin K antagonists and direct oral anticoagulants
  • Journal: Thrombosis research
  • Treatment Used: Surgery
  • Number of Patients: 779
  • Published —
The study researched the outcomes of surgery in patients with hip fracture receiving vitamin K antagonists and direct oral anticoagulants.
Latest Advance
Study
  • Condition: Systemic Sclerosis (SSc)
  • Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Treatment Used: Autologous Hematopoietic Stem Cell Transplantation (AHSCT)
  • Number of Patients: 0
  • Published —
This study reviewed and analyzed the effectiveness and safety of autologous hematopoietic stem cell transplantation (AHSCT)for severe systemic sclerosis (SSc).
Latest Advance
Study
  • Condition: Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
  • Journal: Leukemia & lymphoma
  • Treatment Used: R-CHOP Dose Reduction
  • Number of Patients: 140
  • Published —
This study evaluated the effect of reduced intensity R-CHOP on survival, and toxicity in patients 70 years or older with diffuse large B-cell lymphoma (DLBCL).

Clinical Trials


This doctor has not participated in any recent clinical trials.

Contact

Petah Tiqwa, M, IL

Insurance

Contact them to find out if they accept your insurance plan.